Author:
Singh Pooja,Kumar Pankaj,Jigar Tintodana Komil,Thapa Shikha,Tuli Hardeep Singh,Bansal Poonam,Shahwan Moyad,Garg Vivek Kumar,Bhatia Gurpreet Kaur
Publisher
Springer Nature Singapore
Reference19 articles.
1. Gautam SS, Gautam CS, Garg VK, Singh H (2020) Combining hydroxychloroquine and minocycline: potential role in moderate to severe COVID-19 infection. Exp Rev Clin Pharmacol 13:1183–1190. https://doi.org/10.1080/17512433.2020.1832889
2. Kumar S, Devi C, Sarkar S, Garg VK, Choudhary P, Chopra M, Sharma V, Prakash R (2021) Convalescent plasma: an evidence-based old therapy to treat novel coronavirus patients. In: Biotechnology to combat COVID-19, pp 1–29
3. WHO (2023) Classification of Omicron (B.1.1.529): SARS-CoV-2 variant of concern. https://www.who.int/news/item/26-11-2021-classification-of-omicron-(b.1.1.529)-sars-cov-2-variant-of-concern. Last accessed 25 Jan 2023
4. Zeyaullah M, AlShahrani AM, Muzammil K, Ahmad I, Alam S, Khan WH, Ahmad R (2021) COVID-19 and SARS-CoV-2 variants: current challenges and health concern. Front Genet 12. https://doi.org/10.3389/FGENE.2021.693916
5. Abdallh MA, Husain A, Salman I, Raheem R, Hairunisa N, Amalia H, Alsayed R, Mohammed R, Yousif E (2022) Omicron the new COVID-19 variant, a review. Al-Nahrain J Sci 25:64–67. https://doi.org/10.22401/anjs.25.1.11